Insulin detemir Subcutaneous and Recombinate recombinant
Determining the interaction of Insulin detemir Subcutaneous and Recombinate recombinant and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin detemir
Brand name: Levemir, Levemir FlexPen, Levemir PenFill, Levemir InnoLet, Levemir FlexTouch
Synonyms: Insulin detemir, Insulin Detemir
Generic Name: antihemophilic factor
Brand name: Advate, Adynovate, Afstyla, Eloctate with Fc Fusion Protein, Helixate FS, Kogenate FS, Kovaltry, Novoeight, Nuwiq, Recombinate, Xyntha, Hemofil-M, Koate-DVI, Monoclate-P, Jivi, Obizur
Synonyms: Recombinate (recombinant), Recombinate
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin detemir Subcutaneous-Recombivax
- Insulin detemir Subcutaneous-Recombivax HB
- Insulin detemir Subcutaneous-Recombivax HB Adult
- Insulin detemir Subcutaneous-Recombivax HB Dialysis Formulation
- Insulin detemir Subcutaneous-Recombivax HB Pediatric/Adolescent
- Insulin detemir Subcutaneous-Recort Plus
- Recombinate recombinant-Insulin glargine
- Recombinate recombinant-Insulin Glargine (U-100) Cartridge Systems and Pens
- Recombinate recombinant-Insulin Glargine (U-100) Vials
- Recombinate recombinant-Insulin Glargine (U-300) Pens
- Recombinate recombinant-Insulin glargine and lixisenatide
- Recombinate recombinant-Insulin glargine and lixisenatide Subcutaneous